glp-1 and eyesight Receptor Agonists vision risk GLP-1 Receptor Agonists and the

The FDA declared an end to the shortage of tirzepatide, branded as Mounjaro and Zepbound, in 2024, as well as semaglutide, sold as Wegovy and Ozempic, earlier this year

People who eat very protein and fat-heavy, low-carbohydrate meals tend to report less acute fatigue because the glucose spike-crash mechanism is minimal

The result is a dangerous and unpredictable retention of solids in the stomach, sometimes after as long as 30 hours of fasting

Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy

Probably especially if you're over 50 or pregnant